These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 18594212)

  • 1. In-vitro synergism of m-TOR inhibitors, statins, and classical chemotherapy: potential implications in acute leukemia.
    Calabro A; Tai J; Allen SL; Budman DR
    Anticancer Drugs; 2008 Aug; 19(7):705-12. PubMed ID: 18594212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvastatin enhancement of trastuzumab and classical cytotoxic agents in defined breast cancer cell lines in vitro.
    Budman DR; Tai J; Calabro A
    Breast Cancer Res Treat; 2007 Jul; 104(1):93-101. PubMed ID: 17004104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvastatin synergistically improves the antiproliferative effect of everolimus on rat smooth muscle cells by altering p27Kip1/cyclin E expression.
    Ferri N; Granata A; Pirola C; Torti F; Pfister PJ; Dorent R; Corsini A
    Mol Pharmacol; 2008 Jul; 74(1):144-53. PubMed ID: 18413661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells.
    Taylor-Harding B; Orsulic S; Karlan BY; Li AJ
    Gynecol Oncol; 2010 Dec; 119(3):549-56. PubMed ID: 20837358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma.
    Woodard J; Sassano A; Hay N; Platanias LC
    Clin Cancer Res; 2008 Jul; 14(14):4640-9. PubMed ID: 18628479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
    Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
    Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress.
    Sánchez CA; Rodríguez E; Varela E; Zapata E; Páez A; Massó FA; Montaño LF; Lóopez-Marure R
    Cancer Invest; 2008 Aug; 26(7):698-707. PubMed ID: 18608208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drosophila Lung Cancer Models Identify Trametinib plus Statin as Candidate Therapeutic.
    Levine BD; Cagan RL
    Cell Rep; 2016 Feb; 14(6):1477-1487. PubMed ID: 26832408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro.
    Gorshtein A; Rubinfeld H; Kendler E; Theodoropoulou M; Cerovac V; Stalla GK; Cohen ZR; Hadani M; Shimon I
    Endocr Relat Cancer; 2009 Sep; 16(3):1017-27. PubMed ID: 19509067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agents.
    Budman DR; Calabro A
    Oncology; 2006; 70(2):147-53. PubMed ID: 16645328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia.
    Perl AE; Kasner MT; Tsai DE; Vogl DT; Loren AW; Schuster SJ; Porter DL; Stadtmauer EA; Goldstein SC; Frey NV; Nasta SD; Hexner EO; Dierov JK; Swider CR; Bagg A; Gewirtz AM; Carroll M; Luger SM
    Clin Cancer Res; 2009 Nov; 15(21):6732-9. PubMed ID: 19843663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
    McMillin DW; Ooi M; Delmore J; Negri J; Hayden P; Mitsiades N; Jakubikova J; Maira SM; Garcia-Echeverria C; Schlossman R; Munshi NC; Richardson PG; Anderson KC; Mitsiades CS
    Cancer Res; 2009 Jul; 69(14):5835-42. PubMed ID: 19584292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG CoA reductase inhibitor fluvastatin arrests the development of implanted hepatocarcinoma in rats.
    Paragh G; Kertai P; Kovacs P; Paragh G; Fülöp P; Foris G
    Anticancer Res; 2003; 23(5A):3949-54. PubMed ID: 14666702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
    Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI
    Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells.
    Goard CA; Chan-Seng-Yue M; Mullen PJ; Quiroga AD; Wasylishen AR; Clendening JW; Sendorek DH; Haider S; Lehner R; Boutros PC; Penn LZ
    Breast Cancer Res Treat; 2014 Jan; 143(2):301-12. PubMed ID: 24337703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of statins on fibroblasts from human nasal polyps and turbinates.
    Folli C; Descalzi D; Bertolini S; Riccio AM; Scordamaglia F; Gamalero C; Barbieri M; Passalacqua G; Canonica GW
    Eur Ann Allergy Clin Immunol; 2008 Nov; 40(3):84-9. PubMed ID: 19334372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo.
    Cejka D; Preusser M; Fuereder T; Sieghart W; Werzowa J; Strommer S; Wacheck V
    Anticancer Res; 2008; 28(6A):3801-8. PubMed ID: 19189667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel orally bioavailable inhibitor of phosphoinositol-3-kinase and mammalian target of rapamycin, NVP-BEZ235, inhibits growth and proliferation in multiple myeloma.
    Baumann P; Mandl-Weber S; Oduncu F; Schmidmaier R
    Exp Cell Res; 2009 Feb; 315(3):485-97. PubMed ID: 19071109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway.
    Hu YF; Chen YC; Cheng CC; Higa S; Chen YJ; Chen SA
    J Cardiovasc Electrophysiol; 2009 Feb; 20(2):200-6. PubMed ID: 18775044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray analyses of the effects of NF-kappaB or PI3K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells: synergistic effects of rapamycin on LPS-induced MMP9-overexpression.
    Mendes Sdos S; Candi A; Vansteenbrugge M; Pignon MR; Bult H; Boudjeltia KZ; Munaut C; Raes M
    Cell Signal; 2009 Jul; 21(7):1109-22. PubMed ID: 19285553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.